Firm Flouting Ephedra Ban Faces Product Seizure By U.S. Marshals
This article was originally published in The Tan Sheet
Executive Summary
An FDA-prompted seizure of ephedra products could make it more likely Hi-Tech pharmaceuticals' suit against the FDA over the ephedra ban will go to court, according to the firm